Author

D T Dang

Observed names: D. Dang, D. T. N. Dang, Duc-uy Quang Dang

Institution: Hanoi Medical University

Observed institutions: Hanoi Medical University, University of Michigan, California Pacific Medical Center, Karolinska Institutet, Michigan Medicine, U-M Rogel Cancer Center

ORCID: 0009-0005-2086-3369

Observed ORCID: 0009-0005-2086-3369

OpenAlex ID: A5044407765

CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48

2005 · L H Dang, F Chen, et al. · Oncogene · 51

CDX2 promotes anchorage-independent growth by transcriptional repression of IGFBP-3

2007 · S Y Chun, F Chen, et al. · Oncogene · 22

A Novel Anti‐inflammatory Compound, Artonkin‐4′‐O‐glucoside, from the Leaves of Artocarpus tonkinensis Suppresses Experimentally Induced Arthritis*

2009 · D. T. N. Dang, E. Eriste, et al. · Scandinavian Journal of Immunology · 19

CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45

2005 · L H Dang, F Chen, et al. · Oncogene · 17

229P Integrated cfRNA and ctDNA liquid biopsy for improved early colorectal cancer screening

2025 · T.T. Tran, C.V.T. Nguyen, et al. · Annals of Oncology

S2893 A Rare Case of Metastatic Adenosquamous Cell Carcinoma of the Cecum

2024 · Vishwajit Kode, Rafae Nauman, et al. · The American Journal of Gastroenterology

Methylation as a Mechanism of Cisplatin Resistance in Head and Neck Cancer

2013 · C.T. Viet, D. Dang, et al. · Journal of Oral and Maxillofacial Surgery

Works count: 7

Citation count: 109

H-index: 4

I10-index: 4